Health
Clinical Challenges: When to Add Immunotherapy in Breast Cancer – MedPage Today
Immune checkpoint inhibitors and other immunotherapies may soon have an expanded role
For breast cancer patients, the current indications for immune checkpoint inhibitors (ICIs) are generally limited to triple-negative breast cancer (TNBC), both in high-risk early-stage disease or in the advanced setting for tumors with certain levels of…
Continue Reading
-
General14 hours ago‘We are here for you’: PM to bring help to flood zones
-
General12 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News20 hours agoStudents say new facility would be better in rural areas of Queensland
-
Noosa News12 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call